Foresite Capital Announces CEO Jim Tananbaum Named to Forbes’ Midas List 2017

-- Tananbaum Named Among 100 Best Venture Investors for Third Consecutive Year --

Foresite Capital Announces CEO Jim Tananbaum Named to Forbes' Midas List 2017 (Photo: Business Wire)

Foresite Capital Announces CEO Jim Tananbaum Named to Forbes' Midas List 2017 (Photo: Business Wire)

???pagination.previous??? ???pagination.next???

SAN FRANCISCO--()--Foresite Capital, a healthcare growth equity firm, today announced that Jim Tananbaum, M.D., M.B.A., chief executive officer and managing director, has been named to Forbes’ Midas List of Top Tech Investors for the third consecutive year. The Midas List recognizes the top 100 venture capitalists who “make big, early bets in the leading tech companies of the future and who create exceptional value for their investors.” Dr. Tananbaum is ranked #52 on this year’s list.

Dr. Tananbaum, the founder of Foresite Capital, is an industry leader with 25 years of healthcare entrepreneurial and investing experience. He focuses on strategic, operational and financial opportunities to build franchise healthcare businesses. He is the chief architect of Foresite Capital’s investment organization structure and investment strategy and has played a significant role in numerous Foresite Capital companies. During the last 25 years, he has founded and/or helped grow healthcare franchises in all segments of the healthcare economy. Earlier he was co-founder of GelTex Pharmaceuticals, which brought two drugs to market and was bought for $1.6 billion. He also co-founded Theravance, Inc. and Prospect Venture Partners II and III. He graduated from Yale University with BS/BSEE degrees and earned an M.D. and M.B.A. from Harvard University, and an M.S. from the Massachusetts Institute of Technology.

About Forbes’ Midas List
Forbes develops the Midas List of Top Tech Investors in partnership with TrueBridge Capital Partners by collecting data from publicly available sources, including Dow Jones VentureSource exit data and historical lists, and from direct submissions from venture capital firms. Then, Forbes calculates a ranking for each venture capitalist’s investment in a qualifying company based on generated deal value, size of exit or private valuation and other key metrics, and determines a deal metric ranking against his or her peers. A total deal count score, which determines the ranking by deal count for each venture capitalist, is also determined. Together, the rankings by deal metric and deal count, coupled with a review by experienced institutional investors and venture experts, determine a venture capitalist’s position on The Midas List.

About Foresite Capital
Foresite Capital provides growth capital to emerging healthcare leaders with disruptive products and services across all healthcare sectors in both the private and public markets. The firm is based in San Francisco with an office in New York. For more information, please visit http://www.foresitecapital.com/.

Contacts

Pure Communications
Julia Baron, 415-658-9766
jbaron@purecommunications.com
or
Foresite Capital
Afton Kearney, 415-367-4001
afton@foresitecapital.com

Contacts

Pure Communications
Julia Baron, 415-658-9766
jbaron@purecommunications.com
or
Foresite Capital
Afton Kearney, 415-367-4001
afton@foresitecapital.com